Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge

Eleonora Lai; Pina Ziranu; Francesco Pezzella; Andrea Pretta; Nicole Liscia; Zhiwei Hu

doi:10.3389/fonc.2024.1428174

Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge

Front Oncol. 2024 May 20:14:1428174. doi: 10.3389/fonc.2024.1428174. eCollection 2024.

Authors

Eleonora Lai¹, Pina Ziranu¹, Francesco Pezzella², Andrea Pretta¹, Nicole Liscia³, Zhiwei Hu⁴

Affiliations

¹ Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
² Nuffield Division of Clinical Laboratory Science-Radcliffe Department of Medicine (NDCLS-RDM) John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
³ Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
⁴ Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, United States.

No abstract available

Keywords: anti-angiogenic agents; gastrointestinal cancer; predictive biomarkers; treatment resistance; tumor angiogenesis.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. ZH was supported by two Pelotonia Idea Awards from The Ohio State University Comprehensive Cancer Center Intramural Research Program, a Translational Research Award form International Myeloma Society and Paula and Rodger Riney Foundation, and a Pilot Award from The Ohio State University Breast Cancer Translational Research Program.